Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Grants and Contributions Dataset
Found 508 records

$2,999,580.00

Jul 1, 2022

Individual or sole proprietorship

Agreement:

Operating Grant: POPCoRN Supplement

Number:

166749

Duration: from Jul 1, 2022 to Jun 30, 2023
Description:

To be eligible to the competition, the application must address ALL objectives; the specific objectives of this funding opportunity are to:

• Include a large and robust serosurveillance study of children and youth that can inform research to understand the current state of natural and vaccine-based immunity in this population, and measures to best protect this vulnerable population in Canada;
• Harmonize data collection, and improve open and real-world data sharing with relevant knowledge-users in an accessible, useful and relevant format to support a timely and effective COVID-19 public health response within and across all jurisdictions in Canada as it relates to children and youth;
• Collaborate across Sites to establish resource and data sharing policies, increase efficiencies in research and related processes (including but not limited to ethics review; privacy considerations; contracts; informed-consent; common protocols; developing applications for trial funding; and consistent and valid patient-oriented outcomes), reduce duplication, and maximize research and surveillance activities related to COVID-19 infection and/or vaccination consequences of children and youth;
• Generate research evidence related to COVID-19 infection in diverse children and youth populations, including (but not limited to):
o Equity considerations;
o Health and wellness status (e.g., historically excluded or underserved populations, individuals with complex health needs and/or a disability);
o Sex and gender; and/or
o Racialized and Indigenous (First Nations, Inuit, Métis and Urban Indigenous Peoples) populations; and
• Provide research evidence to inform clinical and health system management and public health response, and/or decision-making and planning within and across jurisdictions in Canada and internationally.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Montréal, QC, CA H3T 1C5

$10,000.00

Jun 22, 2022

Not-for-profit organization or charity

Agreement:

2022 International Society for Vaccines Annual Congress

Number:

A1-015300-05-15

Duration: from Jun 22, 2022 to Jun 22, 2023
Description:

Support provided to the International Society for Vaccines, the world's largest non-commercial, scientific conference for basic and clinical researchers interested in vaccines and underlying sciences.

Organization: National Research Council Canada
Program Name: Collaborative Science, Technology and Innovation Program - Outreach Initiative
Location: Worcester, zz, US MA 01605

$30,000.00

Jun 6, 2022

For-profit organization

Agreement:

Youth - Functional and structural characterization of deuterated mRNA

Number:

991507

Duration: from Jun 6, 2022 to Mar 31, 2023
Description:

To address the challenges of SARS2 COVID-19 pandemic, messenger ribonucleic acid (mRNA) vaccines were developed. While mRNA vaccines and other RNA therapeutics are powerful tools in combatting diseases, their shelf-life is dependent on the integrity of cold chain logistics - the necessity of always storing the vaccine between 4?

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Youth Employment Program
Location: Collingwood, ON, CA L9Y 4V7

$10,000,000.00

Jun 1, 2022

Individual or sole proprietorship

Agreement:

Operating Grant: COVID-19 Outpatient Therapeutic Studies

Number:

166665

Duration: from Jun 1, 2022 to May 31, 2023
Description:

These can include: communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequities; persons with disabilities and individuals across diverse health status (e.g. vaccination status, high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Toronto, ON, CA M5B 1W8

$4,000,000.00

Jun 1, 2022

Individual or sole proprietorship

Agreement:

Op Gr.: Canadian Network of COVID-19 Clinical Trials Networks (CNCCTN) Extension

Number:

165666

Duration: from Jun 1, 2022 to May 31, 2023
Description:

The specific objectives of this funding opportunity are to continue to:
• Provide central coordination and lead collaboration activities with clinical trials groups/networks in a transparent and inclusive manner to increase the availability of high-quality and real-time clinical trial evidence to prevent, diagnose, and/or treat COVID-19 (e.g., through clinical trials of vaccines, therapeutics, or diagnostic tests);
• Collaborate across member networks to expand resource and data sharing policies, including creating data sharing agreements and increasing efficiencies in research and related processes (including, but not limited to ethics review; contracts; common protocols; developing applications for trial funding; consistent and valid patient-oriented outcomes), reduce duplication, and maximize research impact for COVID-19;
• Enhance local, national and/or international clinical trial collaborative efforts by aligning clinical trials networks with other COVID-19 research investments to prevent and/or mitigate the rapid spread of COVID-19 and related negative consequences; and
• Engage stakeholders in research prioritization and oversight, provide evidence to inform clinical/ health system management and public health responses, and/or decision-making and planning within and across jurisdictions in Canada and internationally.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Toronto, ON, CA M4N 3M5

$1,250,000.00

Jun 1, 2022

Individual or sole proprietorship

Agreement:

Operating Grant: COVID-19 Outpatient Therapeutic Studies
- Indirect Costs

Number:

166666

Duration: from Jun 1, 2022 to May 31, 2023
Description:

These can include: communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequities; persons with disabilities and individuals across diverse health status (e.g. vaccination status, high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research.

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Toronto, ON, CA M5B 1W8

$75,000.00

Jun 1, 2022

For-profit organization

Agreement:

ARP – Development of a neutralizing antibody detection kit to accelerate the development of vaccines and immunotherapies.

Number:

990628

Duration: from Jun 1, 2022 to Jun 30, 2023
Description:

Development of a neutralizing antibody detection kit to accelerate the development of vaccines and immunotherapies.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Quebec, QC, CA G1X 3P4

$25,000.00

May 1, 2022

For-profit organization

Agreement:

Product and Business Development of Novel Lipid Molecules for Drug and Vaccine Delivery.

Number:

989820

Duration: from May 1, 2022 to Dec 31, 2022
Description:

During the recent Covid-19 pandemic, some novel lipid molecules became the key ingredient in developing mRNA and DNA-based vaccines against Covid-19 (SARS-CoV-2).

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Youth Employment Program
Location: Edmonton, AB, CA T6E 5V2

For-profit organization

Agreement:

Eyam Vaccines and Immunotherapeutics Ltd.

Number:

18677757

Duration: from Apr 25, 2022 to Sep 3, 2022
Description:

Through the application of national and local priorities, the CSJ program seeks to provide youth, particularly those who face barriers to employment with access to work opportunities. Funded employers must demonstrate that they are providing quality work experiences for youth that provide opportunities to develop and improve their skills.

Organization: Employment and Social Development Canada
Program Name: Youth - Canada Summer Jobs
Location: Surrey, BC, CA V4A4N2

$6,000,000.00

Apr 1, 2022

Individual or sole proprietorship

Agreement:

Canadian Immunization Research Network (CIRN): Funding Extension

Number:

162588

Duration: from Apr 1, 2022 to Mar 31, 2024
Description:

The objectives of the extension are aligned with the Canadian Immunization Research Network (CIRN) 2016 and the CIRN: COVID-19 Vaccine Readiness are:
• To maintain the baseline activities of CIRN. This includes support for its infrastructure of networks to facilitate collaborative research among vaccine and immunization researchers, clinicians, public health professionals and policy makers.
• To support CIRN’s COVID-19 activities related to critical research in the research areas of the COVID-19 Vaccine Readiness grant (vaccine clinical trials [incl. vaccine safety and effectiveness studies]; population prioritization and modelling; vaccine hesitancy and uptake; and coordination and information sharing. The research activities within these research areas will address the evolving COVID-19 vaccine research needs of Canada, and will provide vaccine-related research outcomes to inform effective, equitable and timely COVID-19 public health decision-making .

Organization: Canadian Institutes of Health Research
Program Name: Research in Priority Areas
Location: Halifax, NS, CA B3H 3J5
Date modified: